EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...

cobas 5800 is a new compact addition to the Roche molecular diagnostics portfolio that provides a scalable, high performance testing solution for labs of all sizes. Infectious diseases, such as HIV, ...

In vitro diagnostics (IVD) is an umbrella term for tests conducted on blood or tissue samples to detect diseases, determine the efficacy of novel or established treatments, and monitor health.

Last spring, a rapid polymerase chain reaction (PCR) test for COVID-19 — developed by Northwestern University spinoff company Minute Molecular Diagnostics — received emergency use authorization (EUA) ...

After the start of the SARS-C0V-2 pandemic, investigators from ResearchPath LLC and their collaborators at Rutgers University quickly dedicated resources to develop accurate and reliable COVID-19 ...

Cytespace Africa Laboratories (Cytespace), an MLM Medical Labs company and the only fully CAP-accredited central laboratory in South Africa, has significantly expanded its molecular testing ...

Point-of-care PCR testing for STIs in the ED reduced length of stay and improved antibiotic stewardship compared with central laboratory testing.

Polymerase Chain Reaction Market To Reach US$31.3Bn By 2033 Persistence Market Research. EINPresswire/ -- The global polymerase chain reaction (PCR) market, integral to molecular diagnostics and life ...

GREENWICH — How many people are getting their noses swabbed at COVID-19 testing sites anymore? Not many. Greenwich Hospital is conducting approximately 70 percent less molecular COVID-19 tests than it ...

The "Navigating Regulatory Compliance Whilst Developing and Distributing Polymerase Chain Reaction (PCR)-Based IVD Tests Training Course (May 15, 2026)" has been added to ResearchAndMarkets.com's ...